ABO Genotyping of Complete Hydatidiform Moles
It has been suggested that the ABO blood group of a patient and her partner influence the clinical outcome for patients having a pregnancy with a complete hydatidiform mole (CHM). Since CHM lack red blood Cells, it has not previously been possible to type CHM serologically and investigate the relati...
Main Authors: | R. A. Fisher, P. H. Johnson, S. Povey, D. A. Hopkinson, S. D. Lawler |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1993-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/1993/750349 |
Similar Items
-
ABO Genotyping of Complete Hydatidiform Moles
by: Gerard T. Venneker, et al.
Published: (1993-01-01) -
Trend of Complete Hydatidiform Mole
by: K Thapa, et al.
Published: (2010-03-01) -
Molecular and immunohistochemical characteristics of complete hydatidiform moles
by: Kubelka-Sabit KB, et al.
Published: (2017-06-01) -
Coexisting complete hydatidiform mole & live pregnancy
by: M Kiran, et al.
Published: (2020-01-01) -
Dysregulation of Placental Functions and Immune Pathways in Complete Hydatidiform Moles
by: Jennifer R. King, et al.
Published: (2019-10-01)